Polyclonal Antibody to Bcl2 Associated X Protein (Bax)
| Code | Size | Price |
|---|
| PAB343Po01-20ul | 20ul | £95.00 |
Quantity:
| PAB343Po01-100ul | 100ul | £180.00 |
Quantity:
| PAB343Po01-200ul | 200ul | £245.00 |
Quantity:
| PAB343Po01-1ml | 1ml | £566.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Host Type: Caprine (Goat)
Antibody Clonality: Polyclonal
Regulatory Status: RUO
Target Species: Porcine (pig)
Applications:
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Immunocytochemistry (ICC)
- Immunohistochemistry- Frozen Section (IHC-F)
- Immunohistochemistry- Paraffin Embedded (IHC-P)
- Western Blot (WB)
Documents
Further Information
Alternative Names:
BCL2L4; Bax Zeta; Apoptosis regulator BAX; Bcl-2-like protein 4
Buffer Formulation:
PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
Item Name:
Bcl2 Associated X Protein
Reactivity:
Hu;Mu;Ra;
Source:
Polyclonal antibody preparation
Usage:
Western blotting: 0.5-2ug/mL;1:270-1100
Immunohistochemistry: 5-20ug/mL;1:27-110
Immunocytochemistry: 5-20ug/mL;1:27-110
Optimal working dilutions must be determined by end user.
Immunohistochemistry: 5-20ug/mL;1:27-110
Immunocytochemistry: 5-20ug/mL;1:27-110
Optimal working dilutions must be determined by end user.
Related Products
| Product Name | Product Code | Supplier | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Immunogen | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Recombinant Bcl2 Associated X Protein (Bax) | RPB343Po01 | Cloud-Clone Corp. | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||